FIELD: chemistry.
SUBSTANCE: invention relates to the novel sterically hindered phenols which are intermediate compounds for the further functionalisation of 2,6-diisobornyl phenol,
,
where the isobornyl fragments have the configuration (1S, 2R, 4R, 1'R, 2'S, 4'S), where the isobornyl fragments have the configuration (1S, 2R, 4R, 1'S, 2'R, 4'R) and (1R, 2S, 4S 1'R, 2'S, 4'S), R1 is a formyl group or a group of general formula II -(CH2)nNX2, where X is a C1-C8 alkyl radical, straight or branched, cyclohexyl-, morpholine-, piperidine-, benzyl-, salsolidine, salsoline, N-benzyl-1-phenylethylamine, n=1-10.
EFFECT: high output.
2 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
2,6-DIISOBORNYLPHENOLS | 2011 |
|
RU2502719C2 |
TETRA-(MESO-ARYL)-PORPHYRIN WITH DIISOBORNYLPHENOL SUBSTITUTES IN MACROCYCLE | 2012 |
|
RU2496761C1 |
N-BORNIL- AND N-PHENCHYLCARBOXAMIDES USED AS ORTHOPOXVIRUS REPLICATION INHIBITORS | 2022 |
|
RU2800448C1 |
CHIRAL ZINC COMPLEXES WITH ETHYLENEDIAMINE TERPENE DERIVATIVES | 2022 |
|
RU2785281C1 |
COUMARINS WITH BICYCLIC MONOTERPENE SUBSTITUTES | 2019 |
|
RU2707103C1 |
CHIRAL S-MONO-PERPENYL-CYSTEINES | 2018 |
|
RU2689381C1 |
METHOD OF OBTAINING CHIRAL S-MONOTHERPENALCISTINES | 2018 |
|
RU2675238C1 |
DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
BENZOXAZOLONE DERIVATIVES SHOWING ANTIINFLAMMATORY ACTIVITY | 1991 |
|
RU2024512C1 |
Authors
Dates
2016-02-20—Published
2011-07-06—Filed